Clinical Trial Update: A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating 99mTC-EC-DG SPECT/CT versus PET/CT for lung cancer, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Cell>Point LLC | Conditions: Lung Cancer | Phase 3 | Status: NOT_YET_RECRUITING